Erebrospinal Fluid Management (CSF) Devices - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510240481

Publication Date:

October 14, 2024

Pages:

123

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Erebrospinal Fluid Management (CSF) Devices was estimated to be worth US$ 42 million in 2023 and is forecast to a readjusted size of US$ 50 million by 2030 with a CAGR of 2.4% during the forecast period 2024-2030
The cerebrospinal fluid (CSF) management devices market has been experiencing significant growth and is expected to continue to do so in the coming years. This trend can be attributed to several factors: Increasing prevalence of neurological disorders: Neurological disorders such as hydrocephalus, traumatic brain injury, brain tumors, and meningitis are on the rise globally. These conditions often require CSF management to alleviate symptoms and improve patient outcomes. The growing incidence of these disorders is driving the demand for CSF management devices.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Erebrospinal Fluid Management (CSF) Devices, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Erebrospinal Fluid Management (CSF) Devices by region & country, by Type, and by Application.
The Erebrospinal Fluid Management (CSF) Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erebrospinal Fluid Management (CSF) Devices.
麻豆原创 Segmentation
By Company
Medtronic
Stryker Corporation
Terumo Corporation
Integra Lifesciences
Boston Scientific Corporation
Penumbra
B. Braun Group
Nevro
LivaNova
Natus Medical
Segment by Type:
Fixed
Adjustable
Segment by Application
Hospitals and Clinics
Diagnostic Laboratory
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Erebrospinal Fluid Management (CSF) Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Erebrospinal Fluid Management (CSF) Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Erebrospinal Fluid Management (CSF) Devices in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Erebrospinal Fluid Management (CSF) Devices Product Introduction
1.2 Global Erebrospinal Fluid Management (CSF) Devices 麻豆原创 Size Forecast
1.2.1 Global Erebrospinal Fluid Management (CSF) Devices Sales Value (2019-2030)
1.2.2 Global Erebrospinal Fluid Management (CSF) Devices Sales Volume (2019-2030)
1.2.3 Global Erebrospinal Fluid Management (CSF) Devices Sales Price (2019-2030)
1.3 Erebrospinal Fluid Management (CSF) Devices 麻豆原创 Trends & Drivers
1.3.1 Erebrospinal Fluid Management (CSF) Devices Industry Trends
1.3.2 Erebrospinal Fluid Management (CSF) Devices 麻豆原创 Drivers & Opportunity
1.3.3 Erebrospinal Fluid Management (CSF) Devices 麻豆原创 Challenges
1.3.4 Erebrospinal Fluid Management (CSF) Devices 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Erebrospinal Fluid Management (CSF) Devices Players Revenue Ranking (2023)
2.2 Global Erebrospinal Fluid Management (CSF) Devices Revenue by Company (2019-2024)
2.3 Global Erebrospinal Fluid Management (CSF) Devices Players Sales Volume Ranking (2023)
2.4 Global Erebrospinal Fluid Management (CSF) Devices Sales Volume by Company Players (2019-2024)
2.5 Global Erebrospinal Fluid Management (CSF) Devices Average Price by Company (2019-2024)
2.6 Key Manufacturers Erebrospinal Fluid Management (CSF) Devices Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Erebrospinal Fluid Management (CSF) Devices Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Erebrospinal Fluid Management (CSF) Devices
2.9 Erebrospinal Fluid Management (CSF) Devices 麻豆原创 Competitive Analysis
2.9.1 Erebrospinal Fluid Management (CSF) Devices 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Erebrospinal Fluid Management (CSF) Devices Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erebrospinal Fluid Management (CSF) Devices as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Fixed
3.1.2 Adjustable
3.2 Global Erebrospinal Fluid Management (CSF) Devices Sales Value by Type
3.2.1 Global Erebrospinal Fluid Management (CSF) Devices Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Erebrospinal Fluid Management (CSF) Devices Sales Value, by Type (2019-2030)
3.2.3 Global Erebrospinal Fluid Management (CSF) Devices Sales Value, by Type (%) (2019-2030)
3.3 Global Erebrospinal Fluid Management (CSF) Devices Sales Volume by Type
3.3.1 Global Erebrospinal Fluid Management (CSF) Devices Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Erebrospinal Fluid Management (CSF) Devices Sales Volume, by Type (2019-2030)
3.3.3 Global Erebrospinal Fluid Management (CSF) Devices Sales Volume, by Type (%) (2019-2030)
3.4 Global Erebrospinal Fluid Management (CSF) Devices Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals and Clinics
4.1.2 Diagnostic Laboratory
4.1.3 Other
4.2 Global Erebrospinal Fluid Management (CSF) Devices Sales Value by Application
4.2.1 Global Erebrospinal Fluid Management (CSF) Devices Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Erebrospinal Fluid Management (CSF) Devices Sales Value, by Application (2019-2030)
4.2.3 Global Erebrospinal Fluid Management (CSF) Devices Sales Value, by Application (%) (2019-2030)
4.3 Global Erebrospinal Fluid Management (CSF) Devices Sales Volume by Application
4.3.1 Global Erebrospinal Fluid Management (CSF) Devices Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Erebrospinal Fluid Management (CSF) Devices Sales Volume, by Application (2019-2030)
4.3.3 Global Erebrospinal Fluid Management (CSF) Devices Sales Volume, by Application (%) (2019-2030)
4.4 Global Erebrospinal Fluid Management (CSF) Devices Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Erebrospinal Fluid Management (CSF) Devices Sales Value by Region
5.1.1 Global Erebrospinal Fluid Management (CSF) Devices Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Erebrospinal Fluid Management (CSF) Devices Sales Value by Region (2019-2024)
5.1.3 Global Erebrospinal Fluid Management (CSF) Devices Sales Value by Region (2025-2030)
5.1.4 Global Erebrospinal Fluid Management (CSF) Devices Sales Value by Region (%), (2019-2030)
5.2 Global Erebrospinal Fluid Management (CSF) Devices Sales Volume by Region
5.2.1 Global Erebrospinal Fluid Management (CSF) Devices Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Erebrospinal Fluid Management (CSF) Devices Sales Volume by Region (2019-2024)
5.2.3 Global Erebrospinal Fluid Management (CSF) Devices Sales Volume by Region (2025-2030)
5.2.4 Global Erebrospinal Fluid Management (CSF) Devices Sales Volume by Region (%), (2019-2030)
5.3 Global Erebrospinal Fluid Management (CSF) Devices Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Erebrospinal Fluid Management (CSF) Devices Sales Value, 2019-2030
5.4.2 North America Erebrospinal Fluid Management (CSF) Devices Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Erebrospinal Fluid Management (CSF) Devices Sales Value, 2019-2030
5.5.2 Europe Erebrospinal Fluid Management (CSF) Devices Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Erebrospinal Fluid Management (CSF) Devices Sales Value, 2019-2030
5.6.2 Asia Pacific Erebrospinal Fluid Management (CSF) Devices Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Erebrospinal Fluid Management (CSF) Devices Sales Value, 2019-2030
5.7.2 South America Erebrospinal Fluid Management (CSF) Devices Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Erebrospinal Fluid Management (CSF) Devices Sales Value, 2019-2030
5.8.2 Middle East & Africa Erebrospinal Fluid Management (CSF) Devices Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Erebrospinal Fluid Management (CSF) Devices Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Erebrospinal Fluid Management (CSF) Devices Sales Value
6.2.1 Key Countries/Regions Erebrospinal Fluid Management (CSF) Devices Sales Value, 2019-2030
6.2.2 Key Countries/Regions Erebrospinal Fluid Management (CSF) Devices Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Erebrospinal Fluid Management (CSF) Devices Sales Value, 2019-2030
6.3.2 United States Erebrospinal Fluid Management (CSF) Devices Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Erebrospinal Fluid Management (CSF) Devices Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Erebrospinal Fluid Management (CSF) Devices Sales Value, 2019-2030
6.4.2 Europe Erebrospinal Fluid Management (CSF) Devices Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Erebrospinal Fluid Management (CSF) Devices Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Erebrospinal Fluid Management (CSF) Devices Sales Value, 2019-2030
6.5.2 China Erebrospinal Fluid Management (CSF) Devices Sales Value by Type (%), 2023 VS 2030
6.5.3 China Erebrospinal Fluid Management (CSF) Devices Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Erebrospinal Fluid Management (CSF) Devices Sales Value, 2019-2030
6.6.2 Japan Erebrospinal Fluid Management (CSF) Devices Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Erebrospinal Fluid Management (CSF) Devices Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Erebrospinal Fluid Management (CSF) Devices Sales Value, 2019-2030
6.7.2 South Korea Erebrospinal Fluid Management (CSF) Devices Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Erebrospinal Fluid Management (CSF) Devices Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Erebrospinal Fluid Management (CSF) Devices Sales Value, 2019-2030
6.8.2 Southeast Asia Erebrospinal Fluid Management (CSF) Devices Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Erebrospinal Fluid Management (CSF) Devices Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Erebrospinal Fluid Management (CSF) Devices Sales Value, 2019-2030
6.9.2 India Erebrospinal Fluid Management (CSF) Devices Sales Value by Type (%), 2023 VS 2030
6.9.3 India Erebrospinal Fluid Management (CSF) Devices Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Medtronic
7.1.1 Medtronic Company Information
7.1.2 Medtronic Introduction and Business Overview
7.1.3 Medtronic Erebrospinal Fluid Management (CSF) Devices Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Medtronic Erebrospinal Fluid Management (CSF) Devices Product Offerings
7.1.5 Medtronic Recent Development
7.2 Stryker Corporation
7.2.1 Stryker Corporation Company Information
7.2.2 Stryker Corporation Introduction and Business Overview
7.2.3 Stryker Corporation Erebrospinal Fluid Management (CSF) Devices Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Stryker Corporation Erebrospinal Fluid Management (CSF) Devices Product Offerings
7.2.5 Stryker Corporation Recent Development
7.3 Terumo Corporation
7.3.1 Terumo Corporation Company Information
7.3.2 Terumo Corporation Introduction and Business Overview
7.3.3 Terumo Corporation Erebrospinal Fluid Management (CSF) Devices Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Terumo Corporation Erebrospinal Fluid Management (CSF) Devices Product Offerings
7.3.5 Terumo Corporation Recent Development
7.4 Integra Lifesciences
7.4.1 Integra Lifesciences Company Information
7.4.2 Integra Lifesciences Introduction and Business Overview
7.4.3 Integra Lifesciences Erebrospinal Fluid Management (CSF) Devices Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Integra Lifesciences Erebrospinal Fluid Management (CSF) Devices Product Offerings
7.4.5 Integra Lifesciences Recent Development
7.5 Boston Scientific Corporation
7.5.1 Boston Scientific Corporation Company Information
7.5.2 Boston Scientific Corporation Introduction and Business Overview
7.5.3 Boston Scientific Corporation Erebrospinal Fluid Management (CSF) Devices Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Boston Scientific Corporation Erebrospinal Fluid Management (CSF) Devices Product Offerings
7.5.5 Boston Scientific Corporation Recent Development
7.6 Penumbra
7.6.1 Penumbra Company Information
7.6.2 Penumbra Introduction and Business Overview
7.6.3 Penumbra Erebrospinal Fluid Management (CSF) Devices Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Penumbra Erebrospinal Fluid Management (CSF) Devices Product Offerings
7.6.5 Penumbra Recent Development
7.7 B. Braun Group
7.7.1 B. Braun Group Company Information
7.7.2 B. Braun Group Introduction and Business Overview
7.7.3 B. Braun Group Erebrospinal Fluid Management (CSF) Devices Sales, Revenue and Gross Margin (2019-2024)
7.7.4 B. Braun Group Erebrospinal Fluid Management (CSF) Devices Product Offerings
7.7.5 B. Braun Group Recent Development
7.8 Nevro
7.8.1 Nevro Company Information
7.8.2 Nevro Introduction and Business Overview
7.8.3 Nevro Erebrospinal Fluid Management (CSF) Devices Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Nevro Erebrospinal Fluid Management (CSF) Devices Product Offerings
7.8.5 Nevro Recent Development
7.9 LivaNova
7.9.1 LivaNova Company Information
7.9.2 LivaNova Introduction and Business Overview
7.9.3 LivaNova Erebrospinal Fluid Management (CSF) Devices Sales, Revenue and Gross Margin (2019-2024)
7.9.4 LivaNova Erebrospinal Fluid Management (CSF) Devices Product Offerings
7.9.5 LivaNova Recent Development
7.10 Natus Medical
7.10.1 Natus Medical Company Information
7.10.2 Natus Medical Introduction and Business Overview
7.10.3 Natus Medical Erebrospinal Fluid Management (CSF) Devices Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Natus Medical Erebrospinal Fluid Management (CSF) Devices Product Offerings
7.10.5 Natus Medical Recent Development
8 Industry Chain Analysis
8.1 Erebrospinal Fluid Management (CSF) Devices Industrial Chain
8.2 Erebrospinal Fluid Management (CSF) Devices Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Erebrospinal Fluid Management (CSF) Devices Sales Model
8.5.2 Sales Channel
8.5.3 Erebrospinal Fluid Management (CSF) Devices Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Medtronic
Stryker Corporation
Terumo Corporation
Integra Lifesciences
Boston Scientific Corporation
Penumbra
B. Braun Group
Nevro
LivaNova
Natus Medical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.